The Book of Sales Methodologies

What's the difference between MEDDIC and SPICED, and do I need both?

MEDDIC is primarily a qualification framework — it helps you determine whether a lead is worth pursuing by identifying metrics, economic buyers, decision criteria, and champions. SPICED goes further by centering the entire sales motion on the customer's desired impact and ongoing relationship, making it better suited for subscription or SaaS businesses where renewals and expansion matter as much as the initial close. If your team is struggling with pipeline quality, start with MEDDIC. If you're losing deals at renewal or struggling with expansion, layer in SPICED.

Which of these seven methodologies works best when you're selling into a buying committee rather than a single decision-maker?

MEDDIC, SPICED, and GPCT all explicitly account for multi-stakeholder deals — MEDDIC through its "Economic Buyer" and "Champion" steps, SPICED through its "Decision" component which maps the decision process, committee, and criteria separately. BANT is the weakest fit here because it assumes a single authority figure, which the cheat sheet directly calls out as one of the reasons it's become outdated. For complex committee deals, SPICED's decision mapping is the most structured of the seven.

My reps are already using one methodology — do they need to pick a new one or can these be combined?

The cheat sheet is explicit that combining methodologies is not just acceptable but often the better move — the Sandler chapter specifically suggests using it alongside MEDDIC or SPICED depending on where the buyer is in the journey. SPIN Selling pairs well as a questioning framework underneath almost any of the others since it defines question types rather than a full process. The practical approach is to use one framework for qualification (MEDDIC or GPCT) and another for conversation structure (SPIN or Challenger), rather than forcing reps to abandon what's already working.

How do I know if my reps are actually applying the Challenger methodology correctly versus just being aggressive or pushy?

The cheat sheet flags this directly — the risk with Challenger is reps who push too hard, come across as arrogant, or don't know when to back down. The signal that it's working is that the prospect is being led to a new perspective through data and evidence, not pressure — the reframe step should feel educational, not confrontational. If reps are skipping the "Warm Up" phase and jumping straight to challenging assumptions without deep industry knowledge, they're doing it wrong and it will show up in lost deals and damaged relationships.

What preparation does a rep actually need before running a SNAP Selling conversation with a busy executive?

SNAP requires reps to complete a Buyer's Matrix before the conversation — mapping the executive's role, business objectives, KPIs, external challenges, status quo, change drivers, and change inhibitors. Without that prep, reps default to generic pitches, which is exactly what the "frazzled customer" will ignore or delete. The cheat sheet is clear that SNAP isn't something reps can pick up in a day — it requires genuine expertise in the buyer's market and the discipline to feed the right information at the right time rather than dumping everything at once.

How often should we revisit which methodology our team is using, and what would trigger a switch?

There's no fixed cadence in the cheat sheet, but the practical trigger is a pattern of deal failures at a specific stage — if you're losing deals late because buyers stall on budget, GPCT's fluid budget framing may serve you better than BANT. If win rates are dropping in complex sales, that's a signal to evaluate whether Challenger or MEDDIC qualification is being applied consistently. Revisit methodology fit during quarterly pipeline reviews when you have enough closed-lost data to see where the process is actually breaking down.